to know the unique genetic composition of each patient
sometimes to diagnose cancers(in selected cases)
to decide when to stop (whether further treatment required)
decide if gentler treatment approach will be feasible or not
when all other treatment approaches have exhausted
Real life situation
A 68-year-old patient with lung cancer avoided hospital admission thanks to a targeted tablet, allowing continued daily routines and family life.
A teenager with a rare mutation received a therapy designed for her specific genetic profile leading to remission after conventional drugs failed.
Middle-aged parents managed both cancer and diabetes with a personalized regimen, reducing serious side effect risk and supporting family responsibilities.